Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Placebo-controlled Phase II Trial of MCN36 in Adults With Bipolar Disorder

NCT00109577 is registered in ClinicalTrials.gov with University of Calgary as lead sponsor.

NCT NCT00109577
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00109577 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Placebo-controlled Phase II Trial of MCN36 in Adults With Bipolar Disorder
Lead sponsor
University of Calgary
Phase
Phase 2
Overall status
Terminated
Start date
April 30, 2005
Completion date
March 31, 2009
Enrollment
40 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar disorder